Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection
Griseofulvin administration was associated with the development of absolute neutropenia in six of seven (86%) cats with feline immunodeficiency virus (FIV) infection. The neutropenia was severe (
Gespeichert in:
| Veröffentlicht in: | Journal of veterinary internal medicine 1990-11, Vol.4 (6), p.317-319 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 319 |
|---|---|
| container_issue | 6 |
| container_start_page | 317 |
| container_title | Journal of veterinary internal medicine |
| container_volume | 4 |
| creator | Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA) Grant, C.K Linenberger, M.L Abkowitz, J.L |
| description | Griseofulvin administration was associated with the development of absolute neutropenia in six of seven (86%) cats with feline immunodeficiency virus (FIV) infection. The neutropenia was severe ( |
| doi_str_mv | 10.1111/j.1939-1676.1990.tb03130.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_proquest_miscellaneous_902337223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902337223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5117-c2594ebd193707c2ffdcbe81b17ff947b5871a1c9deece02dd6364d51c6ab92d3</originalsourceid><addsrcrecordid>eNqVkUtvEzEUhS0EKiHwB5CQRmxYTfBjPI7ZIFSVUkihUilZWh77mjrMI7Vn0uTf49FE2dcL-0jn3GP5M0LvCV6QtD5uFkQymZNSlElJvOgrzAjDi_0zNDtZz9EMLyXJy7LAL9GrGDcYU865OENnFIsiqRmqb2EHAbIWhj50W2i9znSMnfG6B5s9-v4--xt8hM4N9c63WX8PQW8PWZJG93FKOKh9C5lvmqHtLDhvPLTmkO18GGKKOjC979rX6IXTdYQ3x3OO7r5e_D7_lq9-XV6df1nlhhMickO5LKCy6SUCC0Ods6aCJamIcE4WouJLQTQx0gIYwNTakpWF5cSUupLUsjn6MPVuQ_cwQOxV46OButYtdENUElPGBE3bHH2akiZ0MQZwaht8o8NBEaxG1mqjRqBqBKpG1urIWu3T8LvjNUPVgD2NHuEm__PkP_oaDk9oVt__XF0zMjbkU4OPPexPDTr8U6Vggqv1z0tV_Fiub27WVK1S_u2Ud7pTevw3dXcrCeGcMPYfzdyp-g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>902337223</pqid></control><display><type>article</type><title>Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection</title><source>Wiley Online Library Open Access</source><creator>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA) ; Grant, C.K ; Linenberger, M.L ; Abkowitz, J.L</creator><creatorcontrib>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA) ; Grant, C.K ; Linenberger, M.L ; Abkowitz, J.L</creatorcontrib><description>Griseofulvin administration was associated with the development of absolute neutropenia in six of seven (86%) cats with feline immunodeficiency virus (FIV) infection. The neutropenia was severe (<400 neutrophils//il) in four of the six affected cats, and one cat died from sepsis. Neutrophil counts returned to baseline values within 15 days after drug withdrawal in all surviving cats. No symptoms or hemato‐logic abnormalities were observed in four normal (FIV‐seronegative) cats treated with the same lot of griseofulvin at equivalent doses. Neutropenia recurred in two of two FIV‐seropositive cats upon griseofulvin rechallenge. Cats with FIV infections appear to be at increased risk for griseofulvin‐associated neutropenia. This phenomenon may be analogous to the increased frequency of antibiotic‐induced neutropenias observed in humans infected with the human immunodeficiency virus.</description><identifier>ISSN: 0891-6640</identifier><identifier>EISSN: 1939-1676</identifier><identifier>DOI: 10.1111/j.1939-1676.1990.tb03130.x</identifier><identifier>PMID: 2074557</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ADVERSE EFFECTS ; Animals ; Cat Diseases - chemically induced ; Cat Diseases - drug therapy ; CATS ; CHAT ; DRUG THERAPY ; EFECTOS SECUNDARIOS ; EFFET SECONDAIRE ; Feline Acquired Immunodeficiency Syndrome - complications ; Feline immunodeficiency virus ; GATO ; GRANULOCITOS ; GRANULOCYTE ; GRANULOCYTES ; GRISEOFULVIN ; Griseofulvin - adverse effects ; Griseofulvin - therapeutic use ; GRISEOFULVINA ; GRISEOFULVINE ; Human immunodeficiency virus ; LENTIVIRINAE ; LEUCOPENIA ; LEUCOPENIE ; LEUKOPENIA ; Male ; Neutropenia - chemically induced ; Neutropenia - complications ; Neutropenia - veterinary ; Prospective Studies ; SIDE EFFECTS ; TERAPEUTICA MEDICAMENTOSA ; THERAPEUTIQUE MEDICAMENTEUSE ; Tinea - complications ; Tinea - drug therapy ; Tinea - veterinary ; TOXICIDAD ; TOXICITE ; TOXICITY</subject><ispartof>Journal of veterinary internal medicine, 1990-11, Vol.4 (6), p.317-319</ispartof><rights>1990 American College of Veterinary Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5117-c2594ebd193707c2ffdcbe81b17ff947b5871a1c9deece02dd6364d51c6ab92d3</citedby><cites>FETCH-LOGICAL-c5117-c2594ebd193707c2ffdcbe81b17ff947b5871a1c9deece02dd6364d51c6ab92d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1939-1676.1990.tb03130.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1939-1676.1990.tb03130.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,11543,27903,27904,45552,45553,46029,46453</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1939-1676.1990.tb03130.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2074557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA)</creatorcontrib><creatorcontrib>Grant, C.K</creatorcontrib><creatorcontrib>Linenberger, M.L</creatorcontrib><creatorcontrib>Abkowitz, J.L</creatorcontrib><title>Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection</title><title>Journal of veterinary internal medicine</title><addtitle>J Vet Intern Med</addtitle><description>Griseofulvin administration was associated with the development of absolute neutropenia in six of seven (86%) cats with feline immunodeficiency virus (FIV) infection. The neutropenia was severe (<400 neutrophils//il) in four of the six affected cats, and one cat died from sepsis. Neutrophil counts returned to baseline values within 15 days after drug withdrawal in all surviving cats. No symptoms or hemato‐logic abnormalities were observed in four normal (FIV‐seronegative) cats treated with the same lot of griseofulvin at equivalent doses. Neutropenia recurred in two of two FIV‐seropositive cats upon griseofulvin rechallenge. Cats with FIV infections appear to be at increased risk for griseofulvin‐associated neutropenia. This phenomenon may be analogous to the increased frequency of antibiotic‐induced neutropenias observed in humans infected with the human immunodeficiency virus.</description><subject>ADVERSE EFFECTS</subject><subject>Animals</subject><subject>Cat Diseases - chemically induced</subject><subject>Cat Diseases - drug therapy</subject><subject>CATS</subject><subject>CHAT</subject><subject>DRUG THERAPY</subject><subject>EFECTOS SECUNDARIOS</subject><subject>EFFET SECONDAIRE</subject><subject>Feline Acquired Immunodeficiency Syndrome - complications</subject><subject>Feline immunodeficiency virus</subject><subject>GATO</subject><subject>GRANULOCITOS</subject><subject>GRANULOCYTE</subject><subject>GRANULOCYTES</subject><subject>GRISEOFULVIN</subject><subject>Griseofulvin - adverse effects</subject><subject>Griseofulvin - therapeutic use</subject><subject>GRISEOFULVINA</subject><subject>GRISEOFULVINE</subject><subject>Human immunodeficiency virus</subject><subject>LENTIVIRINAE</subject><subject>LEUCOPENIA</subject><subject>LEUCOPENIE</subject><subject>LEUKOPENIA</subject><subject>Male</subject><subject>Neutropenia - chemically induced</subject><subject>Neutropenia - complications</subject><subject>Neutropenia - veterinary</subject><subject>Prospective Studies</subject><subject>SIDE EFFECTS</subject><subject>TERAPEUTICA MEDICAMENTOSA</subject><subject>THERAPEUTIQUE MEDICAMENTEUSE</subject><subject>Tinea - complications</subject><subject>Tinea - drug therapy</subject><subject>Tinea - veterinary</subject><subject>TOXICIDAD</subject><subject>TOXICITE</subject><subject>TOXICITY</subject><issn>0891-6640</issn><issn>1939-1676</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkUtvEzEUhS0EKiHwB5CQRmxYTfBjPI7ZIFSVUkihUilZWh77mjrMI7Vn0uTf49FE2dcL-0jn3GP5M0LvCV6QtD5uFkQymZNSlElJvOgrzAjDi_0zNDtZz9EMLyXJy7LAL9GrGDcYU865OENnFIsiqRmqb2EHAbIWhj50W2i9znSMnfG6B5s9-v4--xt8hM4N9c63WX8PQW8PWZJG93FKOKh9C5lvmqHtLDhvPLTmkO18GGKKOjC979rX6IXTdYQ3x3OO7r5e_D7_lq9-XV6df1nlhhMickO5LKCy6SUCC0Ods6aCJamIcE4WouJLQTQx0gIYwNTakpWF5cSUupLUsjn6MPVuQ_cwQOxV46OButYtdENUElPGBE3bHH2akiZ0MQZwaht8o8NBEaxG1mqjRqBqBKpG1urIWu3T8LvjNUPVgD2NHuEm__PkP_oaDk9oVt__XF0zMjbkU4OPPexPDTr8U6Vggqv1z0tV_Fiub27WVK1S_u2Ud7pTevw3dXcrCeGcMPYfzdyp-g</recordid><startdate>199011</startdate><enddate>199011</enddate><creator>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA)</creator><creator>Grant, C.K</creator><creator>Linenberger, M.L</creator><creator>Abkowitz, J.L</creator><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>199011</creationdate><title>Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection</title><author>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA) ; Grant, C.K ; Linenberger, M.L ; Abkowitz, J.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5117-c2594ebd193707c2ffdcbe81b17ff947b5871a1c9deece02dd6364d51c6ab92d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>ADVERSE EFFECTS</topic><topic>Animals</topic><topic>Cat Diseases - chemically induced</topic><topic>Cat Diseases - drug therapy</topic><topic>CATS</topic><topic>CHAT</topic><topic>DRUG THERAPY</topic><topic>EFECTOS SECUNDARIOS</topic><topic>EFFET SECONDAIRE</topic><topic>Feline Acquired Immunodeficiency Syndrome - complications</topic><topic>Feline immunodeficiency virus</topic><topic>GATO</topic><topic>GRANULOCITOS</topic><topic>GRANULOCYTE</topic><topic>GRANULOCYTES</topic><topic>GRISEOFULVIN</topic><topic>Griseofulvin - adverse effects</topic><topic>Griseofulvin - therapeutic use</topic><topic>GRISEOFULVINA</topic><topic>GRISEOFULVINE</topic><topic>Human immunodeficiency virus</topic><topic>LENTIVIRINAE</topic><topic>LEUCOPENIA</topic><topic>LEUCOPENIE</topic><topic>LEUKOPENIA</topic><topic>Male</topic><topic>Neutropenia - chemically induced</topic><topic>Neutropenia - complications</topic><topic>Neutropenia - veterinary</topic><topic>Prospective Studies</topic><topic>SIDE EFFECTS</topic><topic>TERAPEUTICA MEDICAMENTOSA</topic><topic>THERAPEUTIQUE MEDICAMENTEUSE</topic><topic>Tinea - complications</topic><topic>Tinea - drug therapy</topic><topic>Tinea - veterinary</topic><topic>TOXICIDAD</topic><topic>TOXICITE</topic><topic>TOXICITY</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA)</creatorcontrib><creatorcontrib>Grant, C.K</creatorcontrib><creatorcontrib>Linenberger, M.L</creatorcontrib><creatorcontrib>Abkowitz, J.L</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of veterinary internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shelton, G.H. (Pacific Northwest Research Foundation, Seattle, WA)</au><au>Grant, C.K</au><au>Linenberger, M.L</au><au>Abkowitz, J.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection</atitle><jtitle>Journal of veterinary internal medicine</jtitle><addtitle>J Vet Intern Med</addtitle><date>1990-11</date><risdate>1990</risdate><volume>4</volume><issue>6</issue><spage>317</spage><epage>319</epage><pages>317-319</pages><issn>0891-6640</issn><eissn>1939-1676</eissn><abstract>Griseofulvin administration was associated with the development of absolute neutropenia in six of seven (86%) cats with feline immunodeficiency virus (FIV) infection. The neutropenia was severe (<400 neutrophils//il) in four of the six affected cats, and one cat died from sepsis. Neutrophil counts returned to baseline values within 15 days after drug withdrawal in all surviving cats. No symptoms or hemato‐logic abnormalities were observed in four normal (FIV‐seronegative) cats treated with the same lot of griseofulvin at equivalent doses. Neutropenia recurred in two of two FIV‐seropositive cats upon griseofulvin rechallenge. Cats with FIV infections appear to be at increased risk for griseofulvin‐associated neutropenia. This phenomenon may be analogous to the increased frequency of antibiotic‐induced neutropenias observed in humans infected with the human immunodeficiency virus.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2074557</pmid><doi>10.1111/j.1939-1676.1990.tb03130.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0891-6640 |
| ispartof | Journal of veterinary internal medicine, 1990-11, Vol.4 (6), p.317-319 |
| issn | 0891-6640 1939-1676 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_902337223 |
| source | Wiley Online Library Open Access |
| subjects | ADVERSE EFFECTS Animals Cat Diseases - chemically induced Cat Diseases - drug therapy CATS CHAT DRUG THERAPY EFECTOS SECUNDARIOS EFFET SECONDAIRE Feline Acquired Immunodeficiency Syndrome - complications Feline immunodeficiency virus GATO GRANULOCITOS GRANULOCYTE GRANULOCYTES GRISEOFULVIN Griseofulvin - adverse effects Griseofulvin - therapeutic use GRISEOFULVINA GRISEOFULVINE Human immunodeficiency virus LENTIVIRINAE LEUCOPENIA LEUCOPENIE LEUKOPENIA Male Neutropenia - chemically induced Neutropenia - complications Neutropenia - veterinary Prospective Studies SIDE EFFECTS TERAPEUTICA MEDICAMENTOSA THERAPEUTIQUE MEDICAMENTEUSE Tinea - complications Tinea - drug therapy Tinea - veterinary TOXICIDAD TOXICITE TOXICITY |
| title | Severe neutropenia associated with griseofulvin therapy in cats with feline immunodeficiency virus infection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T07%3A22%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20neutropenia%20associated%20with%20griseofulvin%20therapy%20in%20cats%20with%20feline%20immunodeficiency%20virus%20infection&rft.jtitle=Journal%20of%20veterinary%20internal%20medicine&rft.au=Shelton,%20G.H.%20(Pacific%20Northwest%20Research%20Foundation,%20Seattle,%20WA)&rft.date=1990-11&rft.volume=4&rft.issue=6&rft.spage=317&rft.epage=319&rft.pages=317-319&rft.issn=0891-6640&rft.eissn=1939-1676&rft_id=info:doi/10.1111/j.1939-1676.1990.tb03130.x&rft_dat=%3Cproquest_24P%3E902337223%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=902337223&rft_id=info:pmid/2074557&rfr_iscdi=true |